drugset / Trial / NCT00302419

Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction

NCT00302419

Phase 4 Completed 95 enrolled Istanbul University
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators hypothesized that complementary intracoronary streptokinase administration to primary percutaneous intervention in patients with acute myocardial infarction may provide further improvement in myocardial perfusion by dissolving microvascular thrombus \[in situ formed or embolized from proximal site (spontaneous or following PCI)\] and fibrin.

Timeline

Start
2004-10
Primary completion
2006-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Streptokinase Protein / enzyme biologic 250000 iu Other